4-Hydroxy-3-(1-phenylpropyl)-2H-1-benzopyran-2-one; 3-(α-Ethylbenzyl)-4-hydroxy-coumarin; (±)-Phenprocoumon; 3-(1-Phenylpropyl)-4-hydroxycoumarin; 3-(α-Ethylbenzyl)-4-hydroxycoumarin; 3-(α-Phenylpropyl)-4-hydroxycoumarin; 4-Hydroxy-2-oxo-3-(1-phenylpropyl)-2H-chromene; BS 7565; DL-3-(α-Ethylbenzyl)-4-hydroxycoumarin; Falithrom; Fencumar; Liquamar; Marcoumar; Marcumar; Phenprocoumarol; Phenprocoumarole; Ro 1-4849

Phenprocoumon is known for being an oral anti-coagulant. Phenprocoumon is a coumarin derivative that inhibits vitamin K and acts as a long acting oral anticoagulant. It was recently found to act synergistically with flutamide to modulate the stability of the androgen receptor (AR) and resensitize AR-mutant prostate cancer cells to flutamide.